SKIN Valuation

Beauty Health Co

Add to Watchlist

Advanced Chart

1.050

+0.050(+5.000%)

Overview
Forecast
Valuation

SKIN Relative Valuation

SKIN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SKIN is overvalued; if below, it's undervalued.

Historical Valuation

Beauty Health Co (SKIN) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.44 is considered Undervalued compared with the five-year average of 3.93. The fair price of Beauty Health Co (SKIN) is between 20.74 to 35.04 according to relative valuation methord. Compared to the current price of 1.05 USD , Beauty Health Co is Undervalued By 94.94%.

Relative Value

Fair Zone

20.74-35.04

Current Price：1.05

94.94%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

2.53

P/B

Median3y

5.66

Median5y

12.91

12.28

FCF Yield

Median3y

-2.75

Median5y

-2.32

Competitors Valuation Multiple

The average P/S ratio for SKIN's competitors is 36.65, providing a benchmark for relative valuation. Beauty Health Co Corp (SKIN) exhibits a P/S ratio of 0.44, which is -98.81% above the industry average. Given its robust revenue growth of -19.11%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap